Volitionrx Ltd financial data

Symbol
VNRX on NYSE
Location
1489 West Warm Springs Road, Suite 110, Henderson, NV
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31.3 % -49.1%
Debt-to-equity -142 % +48.3%
Return On Equity 85.2 % -66.6%
Return On Assets -240 % -44.6%
Operating Margin -1.78K % +47%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 108M shares +16.8%
Common Stock, Shares, Outstanding 104M shares +25.4%
Entity Public Float 45.5M USD -44.6%
Common Stock, Value, Issued 104K USD +25.4%
Weighted Average Number of Shares Outstanding, Diluted 103M shares +24.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.32M USD +35.1%
Research and Development Expense 11.4M USD -35.1%
Selling and Marketing Expense 4.27M USD -34.6%
General and Administrative Expense 9.13M USD -5.64%
Operating Income (Loss) -23.5M USD +28.4%
Nonoperating Income (Expense) 51K USD -96.3%
Net Income (Loss) Attributable to Parent -23.6M USD +27.6%
Earnings Per Share, Diluted -0.06 USD/shares +25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.3M USD
Accounts Receivable, after Allowance for Credit Loss, Current 190K USD +14%
Other Assets, Current 343K USD -2.19%
Assets, Current 3.26M USD -55.6%
Property, Plant and Equipment, Net 4.5M USD -7.76%
Operating Lease, Right-of-Use Asset 635K USD +24%
Intangible Assets, Net (Excluding Goodwill) 215K USD +137%
Assets 8.7M USD -33.4%
Accounts Payable, Current 2.35M USD -29.8%
Accrued Liabilities, Current 4.39M USD +36%
Contract with Customer, Liability, Current 97.9K USD -22.7%
Liabilities, Current 9.24M USD -70.2%
Operating Lease, Liability, Noncurrent 417K USD +18.9%
Liabilities 41.8M USD +16.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -444K USD -257%
Retained Earnings (Accumulated Deficit) -241M USD -10.7%
Stockholders' Equity Attributable to Parent -31.8M USD -45.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -33.1M USD -44.5%
Liabilities and Equity 8.7M USD -33.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.3M USD +48.5%
Net Cash Provided by (Used in) Financing Activities 3.67M USD
Net Cash Provided by (Used in) Investing Activities -1.81K USD +97.7%
Common Stock, Shares Authorized 325M shares +225%
Common Stock, Shares, Issued 104M shares +25.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -664K USD +92.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.26M USD -62.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 96.7K USD +25.2%
Depreciation 246K USD -11.3%
Payments to Acquire Property, Plant, and Equipment 1.81K USD -93.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -24.2M USD +25.9%
Property, Plant and Equipment, Gross 10.6M USD +11.4%
Operating Lease, Liability, Current 252K USD +32.6%
Additional Paid in Capital 210M USD +7.16%
Amortization of Intangible Assets 14.3K USD -32.3%
Share-based Payment Arrangement, Expense 335K USD -32.2%